Exact Mass: 293.2143

Exact Mass Matches: 293.2143

Found 15 metabolites which its exact mass value is equals to given mass value 293.2143, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Budipine

4,4-Diphenyl-1-tert-butylpiperidine hydrochloride

C21H27N (293.2143)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C93038 - Cation Channel Blocker Budipine is an anti-parkinson agent. Budipine also is a substrate of P-glycoprotein (P-gp), is mediated the uptake into the brain by P-gp. Budipine also is N-methyl-d-aspartate (NMDA) antagonist, and has indirect dopaminergic effects through an improved dopamine release, the inhibition of monoamine oxidase type B (MAO-B). Budipine can be used for the research of CNS disorders include Parkinson disease[1].

   

Butriptyline

dimethyl(2-methyl-3-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)amine

C21H27N (293.2143)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Piperidine, 1-(4,4-diphenylbutyl)-

Piperidine, 1-(4,4-diphenylbutyl)-

C21H27N (293.2143)


   

Prozapine

Prozapine

C21H27N (293.2143)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

daphenylline

daphenylline

C21H27N (293.2143)


   

1,2-diethenylbenzene: N,N-dimethylmethanamine: styrene

1,2-diethenylbenzene: N,N-dimethylmethanamine: styrene

C21H27N (293.2143)


   

N-(4-Cyclohexylphenyl)-4-isopropylbenzenamine

N-(4-Cyclohexylphenyl)-4-isopropylbenzenamine

C21H27N (293.2143)


   

(2R)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

(2R)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

C21H27N (293.2143)


   

(S)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

(S)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

C21H27N (293.2143)


   

BENZYL-[1-(4-CYCLOHEXYLPHENYL)ETHYL]AMINE

BENZYL-[1-(4-CYCLOHEXYLPHENYL)ETHYL]AMINE

C21H27N (293.2143)


   

Pramiverine

Pramiverine

C21H27N (293.2143)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

Piperidine, 1-(4,4-diphenylbutyl)-

Piperidine, 1-(4,4-diphenylbutyl)-

C21H27N (293.2143)


   

4-Phenyl-1-(4-phenylbutyl)piperidine

4-Phenyl-1-(4-phenylbutyl)piperidine

C21H27N (293.2143)


   

Butriptyline

Butriptyline

C21H27N (293.2143)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Budipine

1-tert-butyl-4,4-diphenylpiperidine

C21H27N (293.2143)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C93038 - Cation Channel Blocker Budipine is an anti-parkinson agent. Budipine also is a substrate of P-glycoprotein (P-gp), is mediated the uptake into the brain by P-gp. Budipine also is N-methyl-d-aspartate (NMDA) antagonist, and has indirect dopaminergic effects through an improved dopamine release, the inhibition of monoamine oxidase type B (MAO-B). Budipine can be used for the research of CNS disorders include Parkinson disease[1].